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Background aims: Urinary tract infections (UTIs) are the most common minor complication after 
operations, mostly due to bladder catheterization which used routinely during operations. This 
investigation seeks to determine the prevalence rate, bacterial features, antibiotic sensitivity and risk 
factors for urinary tract infection in postoperative patients in tertiary hospitals in Sana’a, Yemen. 
Methods: This prospective analysis included 390 patients undergoing surgery between 2017 and 
2018 at Al-Thawra Hospital. The study includes 258 male and 132 female ages 5 to 80 years. Clinical 
and demographic data and factors affecting UTIs were collected in the standard questionnaire, and 
the sample was obtained after catheter removal; or, in patients with a clinical indication of 
continuous catheterization, a sample was obtained after the replacement of a new catheter. The 
samples were cultured, examined for significant possible bacterial pathogens, isolated and identified 
by standard laboratory techniques, and microbial sensitivity testing was carried out by disc diffusion 
method. Also operative characteristics associated with postoperative UTI were analysis. Results: 
Postoperative UTI occurred in 144/390 (37%), and the predominant post-operative uropathogen 
was Escherichia coli ( 34%), followed by Pseudomonas aeruginosa 1(27%) and Staphylococcus 
coagulase negative (16.7%). In Gram-negative bacteria, high resistance to ampicillin (95%), nalidixic 
acid (63%), ceftriaxone (68%) and cotrimoxazole (55%) was recorded, while high sensitivity to 
amikacin (98%) and ciprofloxacin. (84%), cefotaxime (87%), gentamicin (87%) and imipenem 
(98%). In Gram-positive bacteria, high resistance to penicillin (90%), erythromycin (85%), and  
amoxicillin (78%) was recorded, while high sensitivity to aztreonam (94%), augmentin (83%),   
ciprofloxacin (93%), cefotaxime (86%), gentamicin (85%) and Rifampicin (100%) and vancomycin 
(97%).  The following characteristics are independently associated with postoperative UTI: female 
sex (OR 2.1, 95% CI 1.3–3.2), Rubber PTFE catheter  (OR 4.7, 95% CI 1.99–11.4), longer duration of 
catheterization >10 days (OR 4.4, 95% CI 2.3–8.3), overweight  (OR 1.7, 95% CI 1.1–2.9), and 
emergency surgery  (OR 1.9, 95% CI 1.2–3.0). Conclusions: POUTI remains an important problem in 
our hospitals and what complicates the situation is that all the causative microorganisms are MDR 
with few treatment options; and several risk factors were independently associated with POUTI. 
KEYWORDS: Catheter associated Urinary tract infections, post operative UTI, POUTI, drug resistance, 
antibiotics,  Sana’a City, Yemen.  
INTRODUCTION 
   Urinary tract infection is the fourth leading cause of healthcare-related infection1 with 
approximately 70% - 80% attributable to inappropriate use of indwelling urinary catheters2. CAUTI 
is associated with increased morbidity and mortality and extended the length of hospital stay2. 
Indwelling bladder catheterization is a known risk factor for developing UTIs 3. There is no widely 
recognized guideline regarding catheterization in the perioperative setting, to date,  with surgeon 
preferred largely bladder management4,5.   Routine catheterization has been used at various surgical 
centers with the purpose of avoid postoperative urinary retention, something for which patients get 
through operation are recognized to be at increased risk, and which itself is associated with UTIs 6,7.  
UTIs account for between 13-15% of all health care-related diseases worldwide, leading to long 
hospital stays, increased health care expenditures, and an increased mortality rate2,8. Postoperative 
UTIs  incidence of has been before estimated as high as 30.26%9. POUTIs are described as the most 
common minor systemic postoperative complication after  operations, exceeding pneumonia, deep 
venous thrombosis,, and renal insufficiency 8.  Also, POUTIs  have been linked to considerable 
unfavorable events such as periprosthetic infection, implant failure, and subsequent revision 
procedures, consequential in extended and costly hospital stays10-14.  This investigation seeks to 
determine prevalence rate, bacterial profile, antibiotic sensitivity and specific risk factors for UTI in 
post operative patients in tertiary hospitals in Sana’a, Yemen. 
SUBJECTS AND METHODS 
  
This prospective analysis included  390 patients undergoing operation  between 2017 and 2018 in  
Al-Thawra Hospital, with indwelling urinary catheters were analyzed for UTI and  antibiogram 
susceptibility , 258 male and 132 female, aged 5 to 80 years. Clinical and demographic data and 
factors effect UTIs  were collected in the standard questionnaire. First ,  the sample was obtained 
after removal of the catheter; or, in patients with a clinical indication for ongoing catheterization, a 
sample was obtained after a new catheter has been placed. Then  the samples were cultured in blood 
agar and MacConkey agar aerobically; cultures were then examined for significant possible bacterial 
pathogens of UTIs. Possible bacterial pathogens were isolated and identified by standard laboratory 
techniques, and microbial sensitivity testing was carried out by disc diffusion method. The antibiotics 
employed in this study were: Aztreonam, Amoxicillin,  Amikacin,  Augmentin,  Ampicillin, 
Ciprofloxacin, Clarithromycin,  Cotrimoxazole, Ceftriaxone,  Cefixime,  Ceftazidime,  Cefotaxime,  
Cefepime,  Gentamicin,  Imipenem, Nalidixic acid,  Nitrofurantoin,  Norfloxacin,  Penicillin,  
Erythromycin, Rifampicin and Vancomycin (Oxide, USA). Inhibition zone was measured after 24 h of  
incubation at 37°C.  The experiments of each antibiotic were performed in triplicate. The results were 
interpreted according to Clinical and Laboratory Standards Institute (CLSI) methodology 15. Also 
operative characteristics associated with postoperative UTI were analysis. 
 DATA ANALYSIS 
The data were statistically analyzed by a software version for statistical significance (Epi Info version 
6, CDC, Atlanta, USA). First rates were calculated, then from two-by-two tables, the independence 
odds ratios* were calculated and P-value was determined using the uncorrected chi square test. 
Fisher’s exact test was used for the small expected cell sizes with a two-tailed probability value.  
* Associated risk factors are generally defined independently in the statistical sense: the variable is 
called an independent risk factor if it has a significant contribution to the outcome in a statistical 
model that includes established risk factors. 
 RESULTS 
   This prospective analysis included  390 patients undergoing operation  between 2017 and 2018 in  
Al-Thawra Hospital, with indwelling urinary catheters were analyzed for UTI and  antibiogram 
susceptibility , 258 male and 132 female, aged 5 to 80 years (Table 1). Postoperative UTI occurs in 
144/390 (37%)  of patients following operations (Table 2). The predominant post-operative  
uropathogen  was Escherichia coli ( 34%), followed by Pseudomonas aeruginosa (27%) and 
Staphylococcus coagulase negative (16.7%) while other bacterial cause were less frequent (Table 4). 
In Gram-negative bacteria, a high resistance to ampicillin (95%),  nalidixic acid (63%), ceftriaxone  
(68%), and cotrimoxazole (55%)  was recorded, while a moderate sensitivity to 
amoxicillin/clavulanate (65%), ciprofloxacin (84%), cefixime (76%) etc, and high sensitivity to 
amikacin (98%),  ciprofloxacin (84%), cefotaxime (87%), gentamicin (87%) and imipenem (98%) 
(Table 5). In Gram-positive bacteria, high resistance to penicillin (90%), erythromycin (85%), and  
amoxicillin (78%) was recorded, while moderate resistance to co-trimoxazole (45%), ceftazidime 
(38%) and cefepime (24%).  High sensitivity to aztreonam (94%), augmentin (83%),   ciprofloxacin 
(93%), cefotaxime (86%), gentamicin (85%) and rifampicin (100%) and vancomycin (97%) was 
recorded (Table 6).  The following characteristics are independently associated with postoperative 
UTI: female sex (OR 2.1, 95% CI 1.3–3.2), Rubber PTFE catheter  (OR 4.7, 95% CI 1.99–11.4), longer 
duration of catheterization >10 days (OR 4.4, 95% CI 2.3–8.3), overweight  (OR 1.7, 95% CI 1.1–2.9), 
and emergency surgery  (OR 1.9, 95% CI 1.2–3.0) (Table 3). 
Discussion 
CAUTI is the most common hospital infection and accounts for about 30-40% of all hospital acquired 
infections and is a major source of hospital sepsis and related deaths in acute care hospitals16. Our 
study examined bacterial POUTI rate in postoperative patients at Al-Thawra University Hospital 
along with testing for common risk factors and common pathogens associated with bacterial post 
operative UTI.  In the current study, the bacterial POUTI rate was found to be 37% (144/390). These 
infections are mainly bacterial infections, and previous studies have shown that about 26% of 
patients who have an indwelling urinary catheter in place for 2-10 days will develop bacteriuria, and 
25% of these patients will develop bacterial CAUTI. Our results are to some extent higher than 
  
published rates perhaps because all of the patients enrolled in this study had undergone operations 
and stayed longer in hospitals and had a number of risk factors that increase the opportunity of the 
development of bacterial CAUTI17,18. Substantial research has been done on nosocomial UTIs in 
general; nevertheless, research on UTIs is strictly limited in postoperative patients 19-22. In this study, 
a number of potential risk factors for the development of bacterial CAUTI were evaluated. Our results 
revealed that 48.5% of patients suffering from bacterial CAUTI were female sex is independently 
associated with postoperative UTI (OR 2.1, 95% CI 1.3–3.2); this is consistent with what has been 
published in other studies 23,24. The mean age of bacterial CAUTI patients in this study was 34.1 ± 
19.3 years and it was noted that only 26.4% of these patients were over 45 years of age; this result 
differs from many studies that reported CAUTI is most common in patients above than 45 years16.  
   The most important risk factor for the development of bacterial CAUTI is the duration of the 
catheterization18. In the current study, the longer catheter period> 10 days was independently 
associated with postoperative urinary tract infection (OR 4.4, 95% CI 2.3-8.3) (Table 3), this result is 
similar to the one previously reported and in which one of the important risk factors for the 
development of bacterial CAUTI is the duration of the catheterization as has been verified in several 
studies23, 26. This association can be explained by that increased duration most probably increases the 
likelihood of microbes ascending to the bladder either around the catheter or through its lumen. Also, 
increased duration of catheterization has been a significant factor associated with acquiring CAUTI in 
this study (>6 days) as has been shown in many other studies 23,26. Also, the two mainly important 
factors that lead to the development of CAUTIs and have been the main focus of quality improvement 
areas are unnecessary urinary catheter placement and inappropriate delay in removing a catheter 
when it is no longer needed27,28.  Regrettably, 38% of attending physicians are unaware that their 
patients have a urinary catheter in place29. In addition, in 20% to 50% of cases, there is no obvious 
indication in favor of catheter placement 1,29.  
   Diabetes mellitus was not significant independently associated with postoperative UTI,  (OR 1.7, 
95% CI 0.8–3.3,p=0.1) (Table 3). These results are disagreement with Saint  et al. and Lobdell et al. 
studies where one of the risk factors for developing CAUTI is diabetes mellitus30,31. Emergency 
surgery was  independently associated with postoperative UTI  (OR 1.9, 95% CI 1.2–3.0) (Table 3). 
With respect to postsurgical patients in further surgical specialties, research reveals that the 
appreciable incidence of postoperative UTIs is not exclusive to type of  surgeries11. One study 
investigating the incidence of postoperative UTIs following major surgeries in various specialties 
revealed that the rates are indeed similar across multiple surgical services: 30-day postoperative UTI 
rate for coronary artery bypass, vascular, colorectal, and TJA surgeries were 3.3, 3.4, 4.0, and 3.4%, 
respectively11. 
   In the current study, the predominant post-operative  uropathogen  was Escherichia coli ( 34%), 
followed by Pseudomonas aeruginosa (27%) and Staphylococcus coagulase negative (16.7%) while 
other bacterial cause were less frequent (Table 4). The current results are different from other 
published nosocomial investigation studies conducted in Europe and North America consistently 
support E. coli, Klebsiella spp., and Enterococci spp. as the predominant bacterial pathogens causing 
CAUTI 32,33.  Also the current study results are different from findings  by Rebmann  and  Greene 
study  ; and Gaynes and Edwards reviews  in which Klebsiella spp. were the most commonly 
identified bacteria (8/16, 50%), followed by Enterococci (7/16, 44%). Although E. coli is known to be 
the most predominant etiology for UTI 24,34, it was isolated from 34% of the positive bacterial culture 
patients enrolled in this study. This finding might suggest dissimilarity in bacterial population 
consistent with different locality and suggests a role of the environment in determining the bacterial 
population in each hospital 35. 
   All bacterial post-operative  uro-pathogens were found to be resistant to most of the tested 
antimicrobials (Tables 5,6). These results are consistent with previous studies that demonstrated 
that organisms recovered from hospitalized  patients are often resistant to multiple antibiotics 36-38. 
The high rate of MDR among nosocomial pathogens reflects the extensive use of antimicrobials in the 
hospital in addition to the huge ability of the organism to acquire resistance genes 39,40.  Amikacin and 
imipenem were the most active drugs against Gram negative bacteria (98% sensitivity).   Rifampicin 
and vancomycin were the most active drugs against Gram positive bacteria (100% and 99% 
  
sensitivity, respectively).  The current findings are similar to that reported by Daef  et al. (2009) 
study and Daef  et al. (2012) in which Gram negative bacteria  Klebsiella spp. were highly sensitive to 
amikacin and imipenem (100% sensitive in 2008, 94.4% in 2010,87.5% in 2013) 41,42.  On the other 
hand, other antibiotics were found to have high and moderate resistance to all bacterial post-
operative  uro-pathogens, and this constant increase in antibiotic resistance over time is frightening 
and creates a risk for patients with it being the only antimicrobial option to isolate MDR. 
CONCLUSION 
Our study has identified multiple characteristics independently associated with postoperative UTIs 
following surgery, which may be helpful to clinicians in categorizing at-risk patients. While this 
information alone may have the potential to improve the quality of patient care, at this time, the 
clinical utility of these risk factors is unproven. Further research such as a prospective study 
stratifying patients into risk groups to guide postoperative management or perioperative 
catheterization may be employed to establish practical utility. 
RECOMMENDATIONS 
CAUTI remains a huge problem in our hospitals and what makes it worse is that all causative 
microorganisms are MDR with few treatment options. According to our results, amikacin, and  
imipenem  can  be used for empirical treatment. The Comprehensive Unit-based Safety national 
program, must be applied  in our hospitals that aim to reduce catheter-associated urinary tract 
infections (CAUTIusts) by focusing on proper technical skills, behavioral changes, education, and 
feedback. Implementation of the CUSP recommendations  to reducing catheter use and CAUTIs in 
post-operative patients. The program will be likely successful because it included both socio-adaptive 
and technical changes and allowed the individual hospitals to customize interventions based on their 
own needs. 
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Table 1: The age and gender distribution of catheterized patients: Characters 
Age groups Male (n= 258) female (n= 132) Total n = 390 
No. % No. % No. % 
< 15 years  46 17.8 26 19.7 72 18.5 
15 – 24 years  30 11.6 20 15.2 50 13 
25 – 34 years  76 29.4 32 24.2 108 27.8 
35 – 44 years  38 14.7 12 9.1 50 12.9 
≥ 45 years  68 26.4 42 31.8 110 28.2 
Total 258 66.2 132 33.8 390 100 
Mean age  34.3 years 32 years 34.1 years 
S D  20 years 18.5 years 19.3 years 
Min  5 years 1 years 1 years 
Max  80 years 70 years 80 years 
Median  30 years 29 years 30 years 
Mode  60 years 40 years 60 years 
 
 
Table 2: The prevalence and association of  postoperative UTI among different sex and  age groups 
 
Factors Positive for POUTI 
N=144 
OR CI X2 p 
No % 
Male n=258 80 31 0.47 0.3-0.7 11.4 <0.001 
Female n=132 64 48.5 2.1 1.3-3.2 11.4 <0.001 
  
< 15 years n=72 20 27.8 0.6 0.3-1.0 3.2 0.07 
15 – 24 years n=50 16 32 0.77 0.4-1.4 0.59 0.43 
25 – 34 years n=108 39 36.1 0.9 0.6-1.5 0.04 0.83 
35 – 44 years n=50 18 36 0.9 0.5-1.7 0.02 0.88 
≥ 45 years n=110 52 47.3 1.4 0.95-2.2 3.0 0.08 
Total n=390 144 37     
OR=odds ratio, CI=confidence interval 95%, X2 =Chi squire, p=p value 
Table 3: The relationship between positive urine culture and types of catheters and it's duration, etc  
among post operative patients 
 
*Independent risk factors Positive for POUTI 
N=144 
OR CI X2 p 
 No %     
Type of catheter  
Silicon catheter  
N=48  
6  12.5  0.2 0.08-0.5 14 <0.001 
Rubber PTFE catheter  
N=342  
138  40.4  4.7 1.99-11.4 14 <0.001 
Duration of catheterization 
1-3days N=182 30 16.5  0.16 0.1-0.2 61 <0.001 
4-6days N=90 41  46.7  1.6 1.0-2.5 3.7 0.05 
7-9days N=68  38  55.9  2.5 1.5-4.3 12.7 <0.001 
>10 days N=50  34  68  4.4 2.3-8.3 23.7 <0.001 
BMI  
Underweight n=77 35 45.5 1.5 0.9-2.5 2.9 0.08 
Normal n=231 70 30.3 0.49 0.3-0.7 10.6 0.001 
Overweight n= 82 39 47.6 1.7 1.1-2.9 5.0 0.02 
Diabetes mellitus n=39 19 48.7 1.7 0.8-3.3 2.5 0.1 
Hypertension n=36 14 38.9 1.1 0.5-2.2 0.06 0.79 
Type of Surgery 
*Elective surgery n=273 87 32 0.49 0.3-0.7 9.0 0.001 
*Emergency surgery n=117 56 48 1.9 1.2-3.0 8.5 0.003 
Amputation n=32 15 47 1.5 0.7-3.2 1.4 0.22 
 Excision n=65 29 44.6 1.5 0.8-2.5 1.9 0.1 
*Others n=293 100 34.1 0.62 0.3-0.9 3.9 0.04 
OR=odds ratio, CI=confidence interval 95%, X2 =Chi squire, p=p value 
*independence is generally defined in a statistical sense: a variable is called an independent risk factor if it has a significant 
contribution to an outcome in a statistical model that includes established risk factors. 
*Elective surgery is done to correct a non-life-threatening condition, and is carried out at the person's request. 
















Table 4:  The frequency of bacterial causative agents of CAUTI in post operative patients 
 
Bacteria Number Percentage % 
Escherichia coli 49 34 
Klebsiella pneumoniae 7 4.9 
Pseudomonas aeruginosa 39 27 
Proteus mirabilis 6 4.2 
Coagulase negative Staphylococci 24 16.7 
Enterobacter spp. 5 3.5 
Staphylococcus aureus 11 7.6 
Enterococcus  faecalis 3 2.1 
Total 144 37 
Note: Mixed infection cases were excluded. 
  
 
Table 5: Antibiotic  pattern of 101 Gram negative bacteria  isolated from post operative patients. 
 
Resistance% Sensitive% Antimicrobial agents 
2 98 Amikacin 
35 65 Amoxicillin/ clavulanic acid Augmentin 
95 5 Ampicillin 
16 84 Ciprofloxacin 
53 47 Clarithromycin 
55 45 Cotrimoxazole  
68 32 Ceftriaxone 
24 76 Cefixime 
27 73 Ceftazidime  
13 87 Cefotaxime  
26 74 Cefepime 
13 87 Gentamicin 
2 98 Imipenem 
63 37 Nalidixic acid  
29 71 Nitrofurantoin 
7 93 Norfloxacin  
 
Table 6: Antibiotic resistance pattern of 43 Gram positive bacteria. 
 
Resistant% Sensitive% Antimicrobial agents 
78 22 Amoxicillin 
6 94 Aztreonam 
17 83 Augmentin 
15 85 Gentamycin 
7 93 Ciprofloxacin 
25 75 Cefixime 
28 72 Ceftazidime 
14 86 Cefotaxime 
24 76 Cefepime 
45 55 Co-trimoxazole 
90 10 Penicillin 
85 15 Erythromycin 
40 60 Norfloxacin 
0 100 Rifampicin 
3 97 Vancomycin 
 
 
 
 
 
